Deficiency of ALADIN impairs redox homeostasis in human adrenal cells and inhibits steroidogenesis

Endocrinology. 2013 Sep;154(9):3209-18. doi: 10.1210/en.2013-1241. Epub 2013 Jul 3.

Abstract

Triple A syndrome is a rare, autosomal recessive cause of adrenal failure. Additional features include alacrima, achalasia of the esophageal cardia, and progressive neurodegenerative disease. The AAAS gene product is the nuclear pore complex protein alacrima-achalasia-adrenal insufficiency neurological disorder (ALADIN), of unknown function. Triple A syndrome patient dermal fibroblasts appear to be more sensitive to oxidative stress than wild-type fibroblasts. To provide an adrenal and neuronal-specific disease model, we established AAAS-gene knockdown in H295R human adrenocortical tumor cells and SH-SY5Y human neuroblastoma cells by lentiviral short hairpin RNA transduction. AAAS-knockdown significantly reduced cell viability in H295R cells. This effect was exacerbated by hydrogen peroxide treatment and improved by application of the antioxidant N-acetylcysteine. An imbalance in redox homeostasis after AAAS knockdown was further suggested in the H295R cells by a decrease in the ratio of reduced to oxidized glutathione. AAAS-knockdown SH-SY5Y cells were also hypersensitive to oxidative stress and responded to antioxidant treatment. A further impact on function was observed in the AAAS-knockdown H295R cells with reduced expression of key components of the steroidogenic pathway, including steroidogenic acute regulatory and P450c11β protein expression. Importantly a significant reduction in cortisol production was demonstrated with AAAS knockdown, which was partially reversed with N-acetylcysteine treatment.

Conclusion: Our in vitro data in AAAS-knockdown adrenal and neuronal cells not only corroborates previous studies implicating oxidative stress in this disorder but also provides further insights into the pathogenic mechanisms in triple A syndrome.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenal Cortex / drug effects
  • Adrenal Cortex / metabolism*
  • Adrenal Cortex Hormones / metabolism*
  • Adrenal Insufficiency / drug therapy
  • Adrenal Insufficiency / etiology
  • Adrenal Insufficiency / metabolism
  • Antioxidants / pharmacology
  • Antioxidants / therapeutic use
  • Apoptosis / drug effects
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Down-Regulation / drug effects
  • Esophageal Achalasia / drug therapy
  • Esophageal Achalasia / etiology
  • Esophageal Achalasia / metabolism
  • Gene Knockdown Techniques
  • Glutathione / metabolism
  • Humans
  • Nerve Tissue Proteins / antagonists & inhibitors
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / metabolism*
  • Neurons / drug effects
  • Neurons / metabolism*
  • Nuclear Pore Complex Proteins / antagonists & inhibitors
  • Nuclear Pore Complex Proteins / genetics
  • Nuclear Pore Complex Proteins / metabolism*
  • Oxidants / pharmacology
  • Oxidation-Reduction
  • Oxidative Stress* / drug effects
  • Phosphoproteins / antagonists & inhibitors
  • Phosphoproteins / genetics
  • Phosphoproteins / metabolism*
  • Protein Synthesis Inhibitors / pharmacology
  • Puromycin / pharmacology
  • RNA, Small Interfering
  • Steroid 11-beta-Hydroxylase / antagonists & inhibitors
  • Steroid 11-beta-Hydroxylase / genetics
  • Steroid 11-beta-Hydroxylase / metabolism*

Substances

  • AAAS protein, human
  • Adrenal Cortex Hormones
  • Antioxidants
  • Nerve Tissue Proteins
  • Nuclear Pore Complex Proteins
  • Oxidants
  • Phosphoproteins
  • Protein Synthesis Inhibitors
  • RNA, Small Interfering
  • steroidogenic acute regulatory protein
  • Puromycin
  • Steroid 11-beta-Hydroxylase
  • Glutathione

Supplementary concepts

  • Achalasia Addisonianism Alacrimia syndrome